A new article of KORTUC (KRC-01) was published in ”BJC Reports”

Title Tumour reoxygenation after intratumoural hydrogen peroxide (KORTUC) injection: a novel approach to enhance radiosensitivity Authors Samantha Nimalasena, John Yarnold, Navita Somaiah et al. Summary A pre-clinical study by the team at The Institute of Cancer Research (ICR), who is conducting the pivotal Phase 2 clinical trial of KORTUC (KRC-01) for breast cancer , was recently published in BJC Reports, a journal in the s Nature Portfolio. The tumour reoxygenation is known as a key factor in overcoming radiation therapy resistance. This article demonstrates tumour reoxygenation by KORTUC in vitro/in vivo model, and shows its promising potential of KORTUC for the treatment of hypoxic tumors across various cancer types. https://www.nature.com/articles/s44276-024-00098-y

The release as fetched from its publisher. kortuc.com ↗